Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

of may prolong skin

In human skin– , digestion of bacterial remnants may sustain late release of after . No dependence of that release on confirmed changes in digestion, with equal of and no , would refute the hypothesis.

Stage of verification

  1. Hypothesis published2026-09-26
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionImmune system

Biological function

The biological function description is being prepared

Direction

Kind of knowledge gap

Established results make incompatible predictions.Clash gap

A double ring marks the main placement where a group contains several values.

Lens
Phagolysosomal catalytic activation
Goal
Совместимость защитных реакций при одновременных нагрузках
Competing hypotheses
2
Published
2026-09-26
As a hypothesis
8 / 10Clarity of mechanism
8 / 10Few extra conditions
9 / 10Completeness of the answer
5 / 10Novelty of the idea
8 / 10Few new entities
8 / 10Decisive experiment
2 / 10Silver-bullet potential
4 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Metabolism and energy

    Lysosomal degradation

    The enzymatic breakdown of engulfed bacterial cell-wall inside phagocyte

    Where this hypothesis actsSkin-associated after , during barrier repair and repeated wetting

    Hypotheses on this target 1
    Lysosomal peptidoglycan degradationInhibition. Hypotheses on this target 11Activation. Hypotheses on this target 0Function preservation. Hypotheses on this target 0Supplementation. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Direct measurement. Hypotheses on this target 0
    • Inhibition1
    • Activation
    • Function preservation
    • Supplementation
    • Feedback restoration
    • Direct measurement

    What is proposed

    Inhibition

    Reversibly slow lysosomal breakdown of after microbial clearance

    With whatNot stated in the record

    HowReversibly inhibit the relevant after microbial clearance; no specific or inhibitor is stated

    Possible result

    Possible reduction in late release of while barrier repair continues

    From the recordОбратимое торможение соответствующего катализа после микробного очищения уменьшит этот выход, а возобновление катализа восстановит его без повторного повреждения барьера.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradation
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Skin may regain its ability to keep substances out while continues underneath. The unexpected move is to locate the continuing trigger inside cells digesting dead bacteria, with repair and repeated wetting proposed to change the timing of that digestion. This is a hypothesis generated by the pipeline, not a measured result in repaired skin.

The proposed mechanism, link by link
  1. Bacterial killing is proposed to leave cell-wall particles inside engulfing immune cells.
  2. Persistent particles are proposed to supply material for continuing digestion inside those cells.
  3. Digestion is proposed to repeatedly activate the specified complex.
  4. Faster skin repair and repeated wetting are proposed to change the rate of that digestion.
  5. The is proposed to shift from leaky to recovered while the internal inflammatory trigger remains active.
  6. Continuing digestion is proposed to produce a late inflammatory peak despite restored barrier function.
A picture for it

A workshop's doors have been repaired, but a shredder inside is still processing leftover material and producing dust. Closing the doors and finishing the cleanup are separate jobs.

Where the picture breaks: Bacterial remains do not simply shed an irritant like dust: the hypothesis requires their digestion to activate a particular cellular process. The picture does not explain why repair or wetting would change that digestion.

  1. Master questionstep 01 of 04

    The goal is a treatment that brings the functional condition of middle-aged human skin closer to that of young people.

    Rests on: The supplied goal names the population and desired direction of improvement, but does not specify which functions or measurements would establish success.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Skin's protective responses should remain compatible when several stresses occur together.

    Rests on: Compatibility between protective responses is selected as one component of youthful skin function.

    Assumption

    The chain assumes that improving compatibility under simultaneous stresses contributes to the desired functional improvement; the master question does not establish that relationship.

  3. Gap questionstep 03 of 04

    Faster restoration of the , the outer protection that limits passage of substances, might prolong by retaining microbial triggers underneath it. The question concerns which order of repair and ending would prevent this during repeated wetting.

    Rests on: The preceding stage supplies the general concern about protective responses interfering with one another, but no specific connection between faster closure, retained microbial triggers and prolonged .

    Leap

    The missing connection is a stated basis for faster barrier closure retaining inflammatory microbial material, and for repeated wetting changing that interaction. The stage raises this possibility without establishing it.

  4. Hypothesisstep 04 of 04

    After bacteria are killed, , cells that engulf material, are proposed to retain , a structural mesh in . Digestion in , -containing compartments that break down material inside cells, would repeatedly activate the , named for nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3. Faster repair and repeated wetting are proposed to alter digestion and produce a late inflammatory peak after the barrier has recovered.S2

    Rests on: S2, a 2016 Cell paper, reports that digestion of bacterial wall material inside engulfing immune cells activates this complex. It supports the digestion-to-activation link, but does not establish persistent particles after bacterial killing, repeated activation in skin, effects of repair or wetting, or a late peak after barrier recovery. Those extensions constitute the proposed mechanism addressing the preceding gap.

    Supported by literature

What is carried, and what is not. Of the six proposed mechanism links listed here, one has direct support for a narrower version: S2 connects digestion of bacterial wall material to activation of the specified complex, without establishing persistence, repetition or repaired skin. No supplied source establishes the sequence end to end; S7, a 2023 Infection and immunity paper, reports production of an inflammatory messenger through a route independent of that complex, which challenges the specificity of the proposed signal but does not test the proposed post-killing sequence in skin.S2S7

Where the reasoning is carried by something unstated · 2
  • Goal pillar. The chain assumes that improving compatibility under simultaneous stresses contributes to the desired functional improvement; the master question does not establish that relationship.
  • Gap question. The missing connection is a stated basis for faster barrier closure retaining inflammatory microbial material, and for repeated wetting changing that interaction. The stage raises this possibility without establishing it. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • A fall and return in , the processed form of an inflammatory messenger, could be credited to the proposed complex even if another route produced it. S7 reports such production independently of that complex in its bacterial wall-processing setting, although it does not establish that alternative in repaired skin.S7 What closes it: The messenger must be measured alongside the proposed activity, meaning activity of an involved in processing inflammatory signals. Attribution to the named complex also requires a test of dependence on that complex; the supplied outline does not specify one.
  • Reduced during a digestion-slowing treatment could reflect cell injury or disrupted internal compartments instead of removal of the proposed trigger. Conversely, an unchanged inflammatory signal would not refute the hypothesis if digestion had not actually changed. What closes it: The design's required independent ways of altering digestion, direct measurements of digestion and checks that cells remain alive must establish that the intended change occurred without nonspecific injury to the digestive compartments.
  • A signal that returns when digestion restarts could be attributed to bacterial remains even if living bacteria persisted or fresh tissue injury caused it. Removing , immune cells involved in recognition of particular targets, addresses the rival involving such recognition but does not exclude the mechanical-injury rival. What closes it: The prediction requires verified absence of living bacteria, equal amounts of initially engulfed wall material, and measurements showing no renewed barrier damage. Cell injury must also be tracked, because restored barrier function alone does not establish that cells are uninjured.

What would make this wrong. The supplied hypothesis identifies its decisive failure as no dependence of late release on particle digestion despite a confirmed change in that digestion. That observation would break the proposed causal sequence if living bacteria were absent, the initially engulfed particle mass was matched, and cell injury or renewed barrier damage did not obscure the comparison.

What it would change. If the proposed sequence held, improving middle-aged skin would require coordinating repair with the handling of bacterial remains: restored barrier function alone would not establish that the inflammatory episode had ended. The work would support testing the proposed order of controlling living microbes, reducing inflammatory activity from their remains and allowing to end during continued repair. Even a positive result in the proposed of human skin and immune cells would not establish a treatment that restores youthful function in people, and the supplied material does not define the numbered outcome measures needed to assess its claimed stabilization.

Sources read · 6

6 literature searches, 5 full texts, 2 abstract-only; 7 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Partly answers it

Cell wall remodeling-dependent morphotype switch in Mycobacterium avium differentially regulates colonization and tissue persistence. · Proceedings of the National Academy of Sciences of the United States of America · 2026

“Macrophage infections demonstrate SmO morphotype–dependent activation of the NLRP3/ASC inflammasome.”

Does not settle: Источник не устанавливает лизосомное расщепление пептидогликана внутри фагоцитов как причину повторной активации NLRP3. Он не изучает кожу, восстановление барьера, циклы намокания, поздний воспалительный пик или показатели SPV_5 и SPV_6.

S2Partly answers it

Hexokinase Is an Innate Immune Receptor for the Detection of Bacterial Peptidoglycan. · Cell · 2016

“Degradation of Gram-positive bacterial cell wall peptidoglycan in macrophage and dendritic cell phagosomes leads to activation of the NLRP3 inflammasome”

Does not settle: Источник не устанавливает сохранение частиц пептидогликана после уничтожения бактерий, повторную активацию в коже, поздний воспалительный пик, влияние репарации или циклов намокания, восстановление барьера и показатели SPV_5 или SPV_6.

S3BackgroundAbstract only

Proteasome-mediated regulation of CpG DNA- and peptidoglycan-induced cytokines, inflammatory genes, and mitogen-activated protein kinase activation. · Shock (Augusta, Ga.) · 2006

“Pretreatment of macrophage cultures with lactacystin, a well-established proteasome inhibitor, significantly repressed tumor necrosis factor alpha secretion and tumor necrosis factor alpha and interleukin 1 beta gene expression”

Does not settle: Источник оставляет открытыми лизосомное расщепление пептидогликана, повторную активацию NLRP3, сохранение частиц клеточной стенки, воспаление кожи, восстановление барьера и влияние намокания или репарации.

S4Background

Collagen-Based Products in Wound, Skin, and Health Care. · Advances in wound care · 2025

“This initial inflammatory response occurs within hours and may last for days while infection surveillance and removal of bacteria and necrotic tissue is performed.”

Does not settle: This source does not establish lysosomal digestion of bacterial cell walls, persistent peptidoglycan particles, NLRP3 reactivation, effects of wetting on this process, a late inflammatory peak after barrier recovery, or the proposed SPV sequence.

S6Partly answers itAbstract only

TRAF6-TAK1-IKKβ pathway mediates TLR2 agonists activating "one-step" NLRP3 inflammasome in human monocytes. · Cytokine · 2023

“Here, we show that in human monocytes, TLR2 agonists such as heat-killed gram-positive bacteria, peptidoglycan (PGN) or synthetic bacterial lipoprotein analog Pam3CysSerLys4 (Pam3CSK4) are able to induce the "one-step" NLRP3 inflammasome activation.”

Does not settle: Источник не устанавливает роль лизосомного расщепления или сохраняющихся частиц пептидогликана, воспаление кожи, его продолжительность, восстановление барьера, циклы намокания либо поздний воспалительный пик.

S7Contradicts it

A Staphylococcal Glucosaminidase Drives Inflammatory Responses by Processing Peptidoglycan Chains to Physiological Lengths. · Infection and immunity · 2023

“SagB-dependent IL-1β production by macrophages is independent of canonical pattern recognition receptor engagement and NLRP3 inflammasome-mediated caspase activity.”

Does not settle: Источник не устанавливает роль лизосомного расщепления остатков клеточной стенки внутри фагоцитов после уничтожения бактерий, повторную активацию NLRP3, поздний воспалительный пик, влияние намокания или репарации барьера, а также показатели SPV_5 и SPV_6.

The gap this hypothesis explains

Two established results predict opposite outcomes, and both cannot be right.

Can faster skin sealing trap microbial triggers and prolong , and what repair order prevents this during repeated wetting?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Может ли ускоренное закрытие продлевать воспаление, сохраняя под ним , и какая последовательность восстановления и прекращения воспаления предотвращает это при повторном намокании?

What this question is asking

The question concerns whether making damaged skin close faster can leave -causing material underneath the repaired surface. It asks whether accelerating restoration of the , the outer protective layer, reduces by limiting further entry or prolongs it by retaining microbes or their products. It also asks how the order of barrier restoration and ending affects that outcome when skin repeatedly becomes wet. The comparison is between different orders of these processes, tracking microbial amounts, passage through the barrier, , and healing over hours or days. The question assumes that barrier protection limits entry while microbial products can continue to stimulate , but the supplied material does not establish the specific supporting mechanism labeled RL-2.

What the terms mean
Skin barrier
The protective outer part of skin that limits passage of water and other material. Its function can recover by degrees; a visibly closed wound does not by itself establish how effectively this protection works.
Barrier restoration or skin sealing
Recovery of the skin's protective surface. The question uses closure as part of this process, but restoration of protective function and visible closure are distinct measurements.
Wound closure
Reduction or disappearance of an open wound area. Several supplied sources report faster closure, without establishing that all microbial triggers have disappeared.
Microbes and microbial triggers
Microbes are microscopic organisms, including bacteria. Microbial triggers are organisms or material from them that can stimulate , so their presence is not measured completely by counting living bacteria.
Microbial metabolites
Substances produced or changed by microbes through their chemical activity. The proposed question treats some of these substances as possible continuing inflammatory triggers; the supplied excerpts do not identify which ones.
Microbial or bacterial burden
The amount of microbes or bacteria present. A decrease in bacterial burden does not by itself establish removal of every microbial product.
Inflammation and its resolution
is the body's tissue response to damage or microbial threats. Resolution means that this response subsides; it need not occur at the same time as surface closure.
Barrier permeability
How readily a measured substance passes through the . The input asks for permeability to return within limits but supplies neither those limits nor the substance to be measured.
Repeated wetting
Skin becoming wet on multiple occasions. The input does not specify the liquid, duration, frequency, or drying intervals, and seawater exposure alone does not establish this repeated pattern.
Bacterial colonization and biofilm
Colonization means bacteria establish themselves at a site. A biofilm is an attached community of microbes within material they produce; S5 describes these communities as aggravating .
Oxidative stress
A condition in which chemically reactive substances exceed the tissue's ability to control them and can cause damage. S1 and S2 describe treatments that reduce these substances or their harmful effects alongside repair-related changes.
Skin-surface cell maturation
The process by which cells acquire the features needed for their roles in the outer skin. S2 reports signs of this process, which are not equivalent to demonstrating complete barrier function.
Bacteria-derived particles
Small membrane-enclosed packages released by bacteria. S1 describes sustained delivery of such particles to support tissue repair after an earlier treatment release.
Atopic dermatitis
An inflammatory skin disorder commonly associated with eczema. It is the disease setting in S3, rather than evidence about all repeatedly wetted skin.
Plasma-activated water
Water treated using an energized gas, changing its chemical properties. S7 evaluates it as a wound-rinsing treatment in seawater-exposed burns in rats.
Ceramides
A class of fatty molecules involved in the skin's protective outer layer. S9 discusses their benefits, but does not establish a sequence for barrier recovery and ending.
Chronic wound and moisture-related skin damage
A chronic wound is one that remains unhealed over a prolonged period. Excessive wound fluid can soften and damage nearby skin, the process discussed in S10.
RL-2
An unexplained label in the pipeline's gap description. The supplied material does not identify its underlying source, mechanism, or measurement, so no more specific definition is established.
What the question takes for granted
Premise not found in what was read
Barrier protection labeled RL-2 predicts reduced penetration, while microbial metabolites labeled RL-2 allow continuing stimulation, creating a possible conflict between accelerated barrier closure and ending.

The assumption links the skin's protective surface with substances made by microbes: repairing the surface would reduce incoming material, but substances already present could keep the tissue inflamed. The supplied input does not explain what RL-2 identifies. If this connection held, the order of removing inflammatory triggers and restoring the surface could help explain why faster closure sometimes helps and sometimes fails to end .

S4 describes how a damaged barrier may allow microbes to reach deeper skin layers, and S5 describes how bacteria and biofilms can aggravate . These support background links, but neither establishes retention of microbial products beneath an accelerated repair or identifies the proposed RL-2 mechanism. None of the supplied excerpts establishes that mechanism under repeated wetting; this absence does not show that the claim is false.S4S5

The same question asked without the part nothing read establishes:

  • During repeated wetting, does faster restoration of the change retained microbial material and the duration of ?
  • During repeated wetting, how does the order of barrier restoration and ending affect microbial amounts, , and healing?
What turns on the answer
  • Faster sealing prolongs If faster sealing retains material that continues to stimulate , surface closure would occur before the underlying inflammatory cause disappears. Closure alone would then overstate recovery, and the order in which microbial stimulation subsides and the barrier closes would affect the outcome.
  • Faster sealing shortens If preventing further microbial entry outweighs any effect of retained material, faster restoration would reduce the continuing supply of inflammatory triggers. Under those conditions, earlier barrier recovery could contribute to earlier resolution of .
  • The effect depends on conditions If reduced entry and retained stimulation contribute differently across wounds or wetting conditions, faster sealing could have different effects on . A sequence associated with recovery in one setting would then not establish the sequence that prevents prolonged in another.
Why it matters

If a damaged barrier allows microbes to enter skin, restoring it could reduce further entry and thereby reduce one source of ; S4 describes the possible entry step. If microbes or their products remain active beneath the restored surface, however, reduced entry would not necessarily remove the existing inflammatory stimulus; this is the question's proposed mechanism, not a demonstrated finding. S5 describes bacteria and their attached communities as aggravating , while S10 reports that excessive wound fluid can damage surrounding skin and delay healing. Confusing visible wound closure with removal of inflammatory triggers could therefore misrepresent recovery, whereas assuming closure necessarily traps those triggers could misrepresent treatments that improve closure and bacterial control together.

What is already established

RL-2 предсказывает уменьшение проникновения; RL-2 допускают продолжающуюся стимуляцию; последовательность вмешательств не проверена.

What would have to be true

За часы или сутки , и воспаление должны последовательно вернуться в заданные пределы без нарушения заживления.

What is missing

Не установлено, при каких условиях ускоренное закрытие сокращает воспаление, а при каких сохраняет его причину и требует иной последовательности лечения.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

После уничтожения бактерий воспаление поддерживает продолжающаяся их внутри . Сохраняющиеся частицы становятся источником повторной активации воспалительного комплекса при . Предполагается, что ускоренная и циклы намокания меняют темп этой переработки, создавая поздний воспалительный пик при уже восстановленной . Проверяемая последовательность: контроль , снижение воспалительной активности перерабатываемых остатков, завершение воспаления при продолжающемся восстановлении . Это должно стабилизировать при контроле .

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

При одинаковой массе и отсутствии поздний выход -1β будет зависеть от скорости частиц. Обратимое торможение соответствующего после уменьшит этот выход, а возобновление восстановит его без повторного повреждения . Эффект сохранится в системе без . Отсутствие зависимости при подтверждённом изменении расщепления опровергнет гипотезу.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies decreased and restored mature interleukin-1β release following changes in catalysis, persistence without T cells, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Доступны человеческой кожи и , , измерение , активности -1 и -1β. Требуются независимые способы изменения и контроль , поскольку неспецифическое повреждение исказит результат.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

При одинаковой массе и отсутствии поздний выход -1β будет зависеть от скорости частиц. Обратимое торможение соответствующего после уменьшит этот выход, а возобновление восстановит его без повторного повреждения . Эффект сохранится в системе без . Отсутствие зависимости при подтверждённом изменении расщепления опровергнет гипотезу.

  • What would separate them

    Faster skin repair may prolong inflammation by bonding microbial peptides to tissue proteins predicts: При одинаковых , механической нагрузке и количестве свободных микробных продуктов ускоренная увеличит содержание микробных и человеческих и продлит ответ . Предотвращение устранит позднее воспаление; добавление выделенных вернёт его без живых бактерий. Эквивалентная смесь несвязанных компонентов даст меньший ответ. Отсутствие при достаточной либо одинаковая активность связанной и свободной форм опровергнет гипотезу.

  • What would separate them

    Rapid skin barrier closure may prolong inflammation through dissipative mechanical damage predicts: В очищенной от микробных компонентов ткани быстрый протокол восстановления вызовет больше , повреждения клеток и более длительный воспалительный ответ, чем плавный протокол с тем же конечным состоянием . При одинаковой длительности протокол, приближающийся к постоянной , уменьшит эти показатели относительно протокола с резкими изменениями. Если измеренная различается, а повреждение и воспаление не меняются, предполагаемая причинная связь опровергнута.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.